ARCH Venture Partners IX, LLC - Insider Trading & Ownership

Entity
Company
Location
8755 W. Higgins Road, Suite 1025, Chicago, IL
Summary
The estimated value of insider holdings of ARCH Venture Partners IX, LLC is at least $161M dollars as of September 7, 2022. ARCH Venture Partners IX, LLC is the 10%+ Owner of Lyell Immunopharma, Inc. and owns shares of Lyell Immunopharma, Inc. (LYEL) stock worth about $83M. ARCH Venture Partners IX, LLC is the 10%+ Owner of Beam Therapeutics Inc. and owns shares of Beam Therapeutics Inc. (BEAM) stock worth about $77.9M. ARCH Venture Partners IX, LLC is the 10%+ Owner of Vir Biotechnology, Inc. and owns shares of Vir Biotechnology, Inc. (VIR) stock worth about $140K.
All Insider Reports
All Insider Reports

Ownership of ARCH Venture Partners IX, LLC

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
LYEL Lyell Immunopharma, Inc. 10%+ Owner $83M Jun 21, 2021
BEAM Beam Therapeutics Inc. 10%+ Owner $77.9M Jun 30, 2021
VIR Vir Biotechnology, Inc. 10%+ Owner $140K Sep 2, 2022

Insider Transactions Reported by ARCH Venture Partners IX, LLC:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.